May 11, 2020
BioSpecifics Reports First Quarter 2020 Financial and Operating Results
Nov 08, 2019
BioSpecifics Reports Third Quarter 2019 Financial and Operating Results
Oct 25, 2019
Endo Presents New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 Fall Meeting of the Sexual Medicine Society of North America (SMSNA)
Oct 10, 2019
BioSpecifics Technologies Corp. Names J. Kevin Buchi as Chief Executive Officer
Sep 05, 2019
Endo to Present New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 American Society for Surgery of the Hand's (ASSH) Annual Meeting
Aug 09, 2019
BioSpecifics Technologies Corp. Reports Second Quarter 2019 Financial and Operating Results
May 17, 2019
Phase 3 Data of Collagenase Clostridium Histolyticum for the Investigational Treatment of Cellulite to Be Presented at The Aesthetic Meeting 2019
May 10, 2019
BioSpecifics Technologies Corp. Reports First Quarter 2019 Financial and Operating Results
Apr 02, 2019
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2018 Financial Results
Mar 18, 2019
BioSpecifics Technologies Corp. Announces Passing of President Thomas L. Wegman
Mar 01, 2019
Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting
Nov 29, 2018
2019 New Treatment Guidelines for Peyronie's Disease
Nov 15, 2018
BioSpecifics Technologies Corp. Appoints Ron Law, Ph.D, J.D., as Senior Vice President of Business Development
Nov 07, 2018
Endo Announces Positive Results from Phase 3 Studies of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite
Oct 31, 2018
BioSpecifics Technologies Corp. Announces Positive Topline Results from Phase 1 Study of CCH for the Treatment of Uterine Fibroids
Aug 09, 2018
BioSpecifics Technologies Corp. Reports Second Quarter 2018 Financial Results
May 09, 2018
BioSpecifics Technologies Corp. Reports First Quarter 2018 Financial Results
Mar 14, 2018
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 12, 2018
BioSpecifics Technologies Corp. Announces Presentation of Interim Data from Phase 1 Study of CCH for the Treatment of Uterine Fibroids at 65th Annual Scientific Meeting of the Society for Reproductive Investigation
Feb 06, 2018
Endo Announces Initiation Of Two Pivotal Phase 3 Clinical Trials Of Collagenase Clostridium Histolyticum For The Treatment Of Cellulite